Ani Pharmaceuticals (ANIP) Shares Repurchased (2021 - 2025)
Ani Pharmaceuticals (ANIP) has disclosed Shares Repurchased for 9 consecutive years, with $611000.0 as the latest value for Q4 2025.
- Quarterly Shares Repurchased rose 92.14% to $611000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Dec 2025, up 11.41% year-over-year, with the annual reading at $12.2 million for FY2025, 11.41% up from the prior year.
- Shares Repurchased hit $611000.0 in Q4 2025 for Ani Pharmaceuticals, down from $1.0 million in the prior quarter.
- In the past five years, Shares Repurchased ranged from a high of $10.0 million in Q1 2025 to a low of $1000.0 in Q4 2021.
- Historically, Shares Repurchased has averaged $1.6 million across 5 years, with a median of $544000.0 in 2023.
- Biggest five-year swings in Shares Repurchased: surged 11800.0% in 2022 and later plummeted 57.62% in 2025.
- Year by year, Shares Repurchased stood at $1000.0 in 2021, then soared by 11800.0% to $119000.0 in 2022, then skyrocketed by 94.12% to $231000.0 in 2023, then skyrocketed by 37.66% to $318000.0 in 2024, then surged by 92.14% to $611000.0 in 2025.
- Business Quant data shows Shares Repurchased for ANIP at $611000.0 in Q4 2025, $1.0 million in Q3 2025, and $551000.0 in Q2 2025.